Why Suicide Risk Protocols Matter for Patients With Chronic Neurological Conditions
Cleveland Clinic’s Revised MS Protocol Highlights the Need for a Clear Response to Suicidal Ideation
When someone is living with multiple sclerosis, Parkinson’s disease, epilepsy, ALS, or another serious neurological condition, medical care often focuses on the physical effects of the disease. Mobility, cognition, pain, medication, speech, and other functional changes can dominate every appointment.
Mental health risk can be easier to miss.
That is one reason a recent change at Cleveland Clinic’s Mellen Center for Multiple Sclerosis deserves attention. In July 2026, Cleveland Clinic announced that the center had revised a suicidal ideation protocol first developed 15 years ago. One of the goals was to make the framework more accessible to clinicians outside behavioral medicine, including neurologists, rehabilitation therapists, speech-language pathologists, and advanced practice providers.
The change recognizes an important clinical reality. A patient experiencing suicidal thoughts may disclose them first to someone who isn’t a psychiatrist or psychologist. The question then becomes whether the health care system has given that clinician a clear way to recognize the concern, assess what needs to happen next, communicate with other providers, and connect the patient with appropriate care.
After a death by suicide, those same questions can become important in determining whether medical care fell below the applicable standard of care and whether a preventable failure contributed to the death.
Multiple Sclerosis Is Associated With Elevated Suicide Risk
Cleveland Clinic describes the suicide risk among people with multiple sclerosis as approximately twice that of the general population and identifies behavioral health as an important part of comprehensive MS care.
Research has consistently found an elevated risk, although estimates vary among studies.
A 2025 systematic review and meta-analysis encompassing 64 studies and more than 200,000 people with MS found increased suicide mortality compared with healthy controls. Researchers also found substantial rates of suicidal ideation and attempts among people living with MS.
Cleveland Clinic’s behavioral health specialists have identified several factors that can be important when evaluating a patient’s individual risk, including depression, anxiety, social isolation, progressive disease, physical and cognitive changes, and the amount of social support available to the patient.
The period following an initial diagnosis deserves particular attention. Cleveland Clinic notes that suicide risk can be especially high among younger patients and during the period immediately following an MS diagnosis.
None of those factors means a particular patient will become suicidal. They do mean clinicians shouldn’t automatically separate the neurological disease from the patient’s emotional health.
The Concern Extends Beyond Multiple Sclerosis
MS isn’t the only neurological disease associated with an increased risk of suicidal thoughts or behavior.
Recent research has documented elevated suicidality among people with Parkinson’s disease and epilepsy. Research involving ALS has also identified heightened psychological vulnerability and suicide risk, particularly during earlier stages of the disease.
The reasons can be complex.
A person may be adjusting to loss of mobility or independence. Cognitive changes can affect daily functioning. Pain and fatigue can become persistent. Employment and relationships may change. Someone who once lived independently may suddenly need assistance with routine activities.
Depression, anxiety, social isolation, and other psychiatric conditions can exist alongside the neurological disease and may substantially affect risk.
Individual assessment remains essential. A diagnosis alone doesn’t establish that someone is suicidal, and symptoms such as fatigue, sleep disturbance, reduced activity, or cognitive difficulty can arise directly from neurological disease as well as depression.
That overlap is one reason a structured process can be valuable.
Screening Is Only the Beginning
Cleveland Clinic’s revised approach makes an especially important point: identifying suicidal ideation isn’t enough if the clinician doesn’t know what to do with that information.
Validated screening tools can help identify patients who may need further assessment. Cleveland Clinic specifically references tools such as the Patient Health Questionnaire-9, while other health care settings use different validated instruments.
But a positive response on a screening tool should trigger a clinical process rather than become another checked box in the medical record.
A meaningful suicide-risk protocol can address several distinct stages:
- Identification: Clinicians need guidance on recognizing suicidal thoughts and other warning signs and determining when additional screening may be appropriate.
- Risk Assessment: The protocol should identify who performs a more complete assessment when concerns emerge and what information needs to be considered.
- Immediate Response: Staff should know what steps to take when a patient appears to face an immediate risk of self-harm.
- Safety Planning: Clinicians can work with the patient to identify warning signs, coping strategies, sources of support, and appropriate crisis resources.
- Communication: Critical information should be communicated appropriately among specialists, behavioral health providers, emergency personnel, and others involved in the patient’s care.
- Follow-Up: The treatment team should know who is responsible for reassessment and continued care after an immediate crisis has passed.
Cleveland Clinic’s revised MS protocol places particular emphasis on helping clinicians move from recognizing risk to taking meaningful action.
Its framework includes personalized safety planning, reducing immediate risks, and clearer procedures for communicating with emergency departments when emergency evaluation may be necessary. Those procedures include safe transport and transferring critical clinical information so the next providers understand why the patient is being sent for additional care.
Why Specialists Outside Behavioral Health Matter
A neurologist, physical therapist, rehabilitation specialist, or speech-language pathologist may spend considerably more time with a patient than a behavioral health provider does.
That can put these clinicians in a position to notice changes.
A patient may begin talking about hopelessness during a rehabilitation appointment. Someone may tell a neurologist that life no longer feels worth living after a significant decline in physical functioning. A therapist may notice increasing withdrawal or hear statements suggesting that the patient feels like a burden to family members.
Those clinicians don’t need to become psychiatrists.
They do need to know what to do when information suggesting possible suicide risk emerges.
That is one of the central ideas behind Cleveland Clinic’s update. The Mellen Center wanted clinicians whose primary expertise lies outside behavioral medicine to have practical guidance for responding appropriately to suicidal ideation.
A system that relies entirely on individual judgment without a clear escalation process can create uncertainty at precisely the moment when clarity matters most.
Warning Signs Need Clinical Context
Some commonly recognized warning signs of suicide can be particularly difficult to interpret in someone with a neurological disease because they overlap with symptoms of the medical condition itself.
Changes that can warrant additional attention may include:
- Expressions of Hopelessness: Statements suggesting the patient believes there is no future or no possibility of adapting to the diagnosis.
- Talking About Being a Burden: Comments indicating that the patient believes family members or caregivers would be better off without them.
- Increasing Social Isolation: Withdrawal from family, friends, treatment, or activities beyond what would ordinarily be expected from physical limitations alone.
- Marked Changes in Mood or Behavior: Significant emotional or behavioral changes that aren’t adequately explained by the known course of the disease.
- Direct Statements About Death or Suicide: Any direct expression of suicidal thinking requires appropriate attention and shouldn’t be dismissed as frustration with the illness.
No single sign proves that a person intends to die by suicide.
Fatigue, sleep disruption, cognitive problems, reduced activity, and loss of independence can all be part of neurological disease. That makes thoughtful assessment more important, not less. Clinicians need to distinguish disease-related symptoms from changes that may indicate depression, suicidal ideation, or another behavioral health concern.
A Health Care Policy Can Matter in a Suicide Malpractice Investigation
When a family questions whether medical negligence contributed to a death by suicide, written policies and protocols can become important evidence.
They aren’t necessarily the legal standard of care by themselves.
Depending on the state and the circumstances, the applicable standard may be established through medical expert testimony, accepted professional practice, regulatory or accreditation requirements, medical literature, and other evidence.
A hospital or medical practice may also adopt an internal policy that is more demanding than what the law otherwise requires. For that reason, simply proving that an employee departed from an internal policy doesn’t automatically prove malpractice in every jurisdiction.
But the policy can still matter.
It may show that an organization recognized a particular risk. It may establish how clinicians were instructed to respond. Training records can show whether staff members were prepared to follow those instructions. The medical chart can then show whether the steps described in the policy were actually taken when concerning information emerged.
The investigation may therefore compare several different forms of evidence rather than focusing on a single document.
What Records Can Help Show What Happened?
Medical records are often central to determining what clinicians knew and when they knew it.
Relevant records can include:
- Neurology and specialty-treatment notes;
- Behavioral health records;
- Suicide screening results;
- Formal suicide risk assessments;
- Nursing and rehabilitation documentation;
- Telephone and patient-portal communications;
- Safety plans;
- Emergency department records;
- Discharge and transfer documentation;
- Medication records;
- Hospital or practice policies;
- Staff training materials; and
- Communications among members of the treatment team.
The timeline can be especially revealing.
A record may show that a patient expressed suicidal thoughts, but not what happened afterward. It may show that one specialist documented concerning behavior without communicating it to another provider. An emergency department may have received the patient without important information from the referring clinician.
On the other hand, the records may show that providers identified the concern, performed an appropriate assessment, created a safety plan, arranged additional care, and reasonably responded to the information available at the time.
A poor outcome doesn’t establish negligence by itself. The question is whether the care provided met the applicable standard under the circumstances and whether any departure from that standard contributed to the death.
Foreseeability Can Become a Critical Issue After a Suicide
Suicide malpractice cases frequently involve questions about foreseeability.
That doesn’t mean a provider is legally responsible whenever a patient dies by suicide.
The analysis can involve whether clinicians knew or reasonably should have recognized that the patient faced a suicide risk requiring additional assessment or precautions, whether the care provided fell below the applicable standard, and whether that failure caused or contributed to the death.
Those issues are highly dependent on the medical facts and the law of the state where the treatment occurred.
A known diagnosis associated with elevated population-level suicide risk doesn’t automatically make an individual patient’s suicide foreseeable. Population data can’t replace an individualized assessment.
But documented risk factors can become significant when combined with information available to the treatment team, such as prior attempts, suicidal statements, severe depression, escalating hopelessness, social isolation, recent major losses, or other warning signs.
Cleveland Clinic’s Protocol Doesn’t Set the Legal Standard for Every Provider
The Mellen Center’s updated approach is significant because it demonstrates how one major health system is responding to recognized suicide risk among patients with chronic neurological disease.
It doesn’t automatically dictate what every neurologist, hospital, rehabilitation facility, or medical practice in the country must do.
Standards of care depend on the circumstances and can vary by provider, setting, jurisdiction, and the patient’s presentation.
Still, developments like this can be relevant to the broader medical discussion. Cleveland Clinic has publicly recognized that suicide prevention in MS care shouldn’t remain isolated within a behavioral health department and that clinicians across disciplines benefit from practical guidance for responding when suicidal ideation emerges.
Other Cleveland Clinic locations are already exploring ways to adapt the framework to their own environments.
That makes the update important not because it creates a new legal rule, but because it illustrates how suicide risk can be integrated into multidisciplinary neurological care.
Could a Failure to Recognize Suicide Risk Support a Malpractice Claim?
Potentially, but every case requires an individual investigation.
A viable claim generally requires considerably more than showing that a patient had MS or another neurological condition and later died by suicide.
The medical and legal questions can include:
- What suicide risk factors were present?
- What did each provider know?
- Were suicidal thoughts or warning signs documented?
- Was an appropriate assessment performed?
- What did the applicable standard of care require?
- Did the provider or facility have relevant policies?
- Were those policies followed?
- Was critical information communicated among providers?
- Was an appropriate safety plan or higher level of care considered when clinically indicated?
- Would appropriate care probably have changed the outcome?
Medical experts are often necessary to evaluate those questions. An expert can compare the actual care with the professional standard applicable to the providers involved and address whether an identified departure probably contributed to the death.
Families Deserve Answers About the Care Their Loved One Received
After a suicide, families often return to the same questions: Were there warning signs? Did anyone recognize them? Was the patient properly assessed? Did the treatment team communicate? Was there a plan for what to do when the risk increased?
Those questions can’t be answered from a diagnosis alone.
They require a careful review of the medical records, the treatment timeline, relevant policies, communications among providers, and the standard of care that applied at the time.
The Law Offices of Skip Simpson, Attorneys and Counselors focuses on suicide, psychiatric malpractice, and failures in mental health care. We represent families across the country who need to understand whether negligent care contributed to the loss of a loved one.
If someone you love died by suicide after concerns about their mental health weren’t properly assessed or addressed during medical care, we can review the circumstances and help you understand what the records show and whether a legal claim may be available.
Contact us for a free, confidential case review. There are no upfront costs under our contingency-fee arrangement, and you aren’t responsible for legal fees or case expenses if there is no recovery.
